QA: Chemocentryx Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001340652_2020_Chemocentryx_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001340652, Chemocentryx Inc

  xvar xval
0 AssetsCurrent 174,362,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,154,000
3 remainder_Assets 32,567,000
4 LiabilitiesCurrent 59,080,000
5 LiabilitiesNoncurrent 20,908,000
6 remainder_Liabilities 63,095,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,647,900
9 ResearchAndDevelopmentExpense 71,885,186
10 remainder_Expenses 0
11 remainder_Revenues 37,476,936
12 remainder_NetIncome 3,819,565
13 remainder_ComprehensiveNetIncome 265,133
  yvar yval
0 Assets 209,083,000
1 Liabilities 143,083,000
2 Expenses 97,533,086
3 Revenues 37,476,936
4 StockholdersEquity 66,000,000
5 NetIncome -56,236,585
6 ComprehensiveNetIncome -56,104,018
7 BaseVar 245,630,360
8 EconomicCapitalRatiobeforeLimitedLiability 0.498
9 EconomicCapitalRatio 1.88

Edgar->Model Mapping

Feature Distribution

Change over Time